NCT04487223 Characterization of Novel Lipoprotein Properties Associated With an Increased Risk to Develop Atherosclerosis Status UNKNOWN Phase N/A
NCT04483167 Clinical Transfer of a Vulnerable Atherosclerotic Plaque Tracer : 99mTc-cAbVCAM1-5 (ATHENA) Status UNKNOWN Phase PHASE1
NCT04460482 Near-infrared Spectroscopy Guided Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Status COMPLETED Phase NA
NCT04424121 CCTA, CACS and ECG Stress Testing in Patients With Suspected CAD: Precision Phenotyping and Financial Evaluation Status UNKNOWN Phase NA
NCT04416425 Hemodynamic Change of Coronary Atherosclerotic Plaque After Evolocumab Treatment Status UNKNOWN Phase N/A
NCT04410003 Metabolic and Metagenomic Effects of Intestinal Microbiome Repopulation in Unexplained Atherosclerosis Status RECRUITING Phase PHASE1
NCT04380467 Vitamin D Supplementation in CKD - Vascular Function, Structure and Immune Regulation Status COMPLETED Phase NA
NCT04368091 Clinical Use and Safety of the Xtreme Touch (Magic Touch PTA)- Neo Sirolimus Coated PTA Balloon Catheter in the Treatment of Infrainguinal Peripheral Arterial Disease Status COMPLETED Phase N/A
NCT04350216 Effect of Sarilumab on Atherosclerotic Disease Assessed by PET/CET in Patients With RA (SARIPET) Status UNKNOWN Phase PHASE4
NCT04240119 Angiogenic Markers in Cerebrovascular Disease (ANFIS) Status ENROLLING_BY_INVITATION Phase N/A
NCT04235023 PTP1B Implication in the Vascular Dysfunction Associated With Obstructive Sleep Apnea Status COMPLETED Phase NA
NCT04221815 IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact Status ACTIVE_NOT_RECRUITING Phase NA
NCT04185493 Coronary Artery Geometry and the Severity of Coronary Atherosclerosis Status UNKNOWN Phase N/A
NCT04181996 Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine Status COMPLETED Phase PHASE3
NCT04167761 Ertugliflozin: Cardioprotective Effects on Epicardial Fat Status COMPLETED Phase EARLY_PHASE1
NCT04152291 The Effect of E-EPA on Circulating LDL and Plasma Lipid Metabolism Status COMPLETED Phase NA